Spelling suggestions: "subject:"IL-1 1receptor"" "subject:"IL-1 2receptor""
1 |
Assessment of serum IL-1 receptor antagonist level and gene polymorphism in patient with coronary artery diseaseKung, Yun-chen 20 June 2007 (has links)
Previous studies show that coronary artery disease (CAD) is a multi-factors and chronic inflammatory disease, and is associated with lipid metabolism. IL-1ra is a naturally occurring anti-inflammatory molecules that block the action of IL-1. However, little is known about the imbalance between IL-1ra and inflammatory mediators in CAD. We attempted to investigate the relationships between inflammatory mediators and serum IL-1ra levels in patients with CAD. In 95 patients with angiographically defined CAD, and 70 healthy controls were studied in a case-control manner. Serum levels of cytokines and the risk factor of CAD were examined. Polymorphisms for IL-1ra gene were detected by PCR, and genotypes and allelic frequencies in both groups were compared. Our major finding include: (1) The risk factors such as elevated BMI, systolic BP, smoking, hypertension, blood glucose, and TG was more frequently found in the CAD group than the control group ( p < 0.001). However, the HDL-C and bilirubin were significantly higher in control group than the CAD group. (2) The relative risk of those in the highest quartile of ratio of LDL-C to HDL-C, TC to HDL-C, and TG to HDL-C were significantly elevated. ( OR = 2.98, p < 0.01; OR = 5.31, p <0.001; OR = 8.43, p < 0.001 respectively) (3) Five different inflammatory markers were significantly elevated including IL-1ra, hs-CRP, IL-6, leukocyte count, and neutrophil percentage between healthy controls and CAD patients. ( p < 0.01) (4) Levels of IL-1ra and other variables such as blood glucose, BMI, TG, IL-6, hs-CRP, and leukocyte count has significantly correlated, and were inversed correlation in bilirubin, and HDL-C in all study subjects. ( p < 0.01) (5) In the multiple logistic regression analysis, adjustment was made for variables. The relative risk of CAD for the highest quartile of IL-1ra, as compared with the lowest quartile, had an Odds ratio 2.57 ( 95% confidence intervals, 1.12 - 5.91, p = 0.026 ) increase in risk for CAD. (6) Similar results were obtained hs-CRP, IL-6 in the highest quartile were increase risk for future CAD. ( OR = 5.86 and 5.79 respectively; p < 0.001) (7) The join effect cytokines of hs-CRP, IL-6, IL-1ra concentrations may play important role in CAD risk. ( OR = 10.19, p < 0.001 ) (8) In addition, IL-1ra allele 2 genotype and allelic frequencies were no significant association with increase in IL-1ra with CAD. In conclusion, we find a significant association of elevated IL-1ra levels in the patients with CAD. Thus, these results support the hypothesis that inflammation, anti-inflammation cytokines and lipoprotein metabolism provide a useful marker for predicting the development of CAD events.
|
2 |
The role of MYD88-dependent receptors in the anti-tumor efficacy of the EGFR inhibitor Erlotinib in head and neck cancerKoch, Adam Taylor 01 July 2014 (has links)
No description available.
|
3 |
Treatment of Knee Osteoarthritis With Orthokine®-Derived Autologous Conditioned SerumFox, Beth A., Stephens, Mary M. 01 May 2010 (has links)
Osteoarthritis (OA) is the most prevalent arthritis in the world with increasing numbers of people expected to acquire the disease as the population ages. Therapies commonly used to manage the disease have limited efficacy and some carry significant risks. Current data suggest that the anti-inflammatory cytokine IL-1 receptor antagonist (IL-1Ra) can alter the inflammatory response and cartilage erosion present in OA. Intra-articular gene expression of IL-1Ra has shown promising results in animal models to provide symptomatic improvement and minimize osteoarthritic changes. Orthogen AG (Dusseldorf, Germany) has developed a method to produce an autologous conditioned serum (ACS) rich in IL-1Ra marketed as Orthokine®. Study participants treated with ACS have improved pain and function; however, these results are preliminary and need confirmation. If ongoing trials prove that ACS can retard cartilage degeneration and reduce inflammation, the management of OA would be dramatically altered, perhaps providing a mechanism to prevent the disease or at least its progression.
|
4 |
The Regulatory Role of Interleukin-1 Receptor Associated Kinase M in Toll-Like Receptor SignalingZhou, Hao 22 April 2016 (has links)
No description available.
|
5 |
Receptor de aerobactina férrica de Escherichia coli - IutA: um novo antígeno T-independente do tipo 1 / Ferric aerobactin receptor from Escherichia coli IutA: a new type 1 T-independent antigenLandgraf, Taise Natali 15 June 2012 (has links)
Alguns fatores de virulência em bactérias de microbiota normal, tais como sideróforos moléculas captadoras de ferro e determinadas fímbrias, possibilitam que esses microorganismos causem infecção quando a colonização ocorre fora de seu habitat normal. Dentre as diferentes espécies bacterianas da microbiota normal com potencial para causar doenças, como as infecções do trato urinário (ITUs), destaca-se Escherichia coli. Certas cepas dessa espécie bacteriana apresentam um plasmídeo (pColV) que contém um gene que codifica IutA, o receptor para a aerobactina férrica, que é um sideróforo frequentemente associado às ITUs. Recentemente, nosso grupo estabeleceu que IutA apresenta a capacidade de induzir proliferação de linfócitos B. Neste trabalho, objetivamos identificar as moléculas e os mecanismos que modulam a proliferação de linfócitos B induzida por IutA recombinante (rIutA) de E. coli. Para avaliar se a proliferação era dependente de outras células, foram realizados ensaios de proliferação de células B marcadas com CFSE utilizando o sobrenadante de macrófagos ou células dendríticas estimulados com rIutA, por 24 horas, ou coculturas em placas de transwell. As análises desses ensaios revelaram que a proliferação das células B induzida por rIutA é dependente de moléculas liberadas por células acessórias, ou seja, ocorre de forma indireta. Os resultados dos ensaios utilizando células deficientes da molécula adaptadora MyD88 mostraram dependência da sinalização por essa molécula nos linfócitos B, mas não nas células acessórias, para que ocorresse a proliferação. Posteriormente, os ensaios in vitro utilizando células de animais deficientes para TLR4, TLR2 e IL-33R mostraram que a sinalização por esses receptores é dispensável. Contrariamente, a utilização do antagonista do receptor de IL-1 reduziu significativamente a proliferação de células B tratadas com esse antagonista. Além disso, identificamos que rIutA leva à expressão de IL-1 em macrófagos e células dendríticas estimuladas com essa proteína. Assim, nossos resultados sugerem que rIutA de E. coli induz a proliferação policlonal de linfócitos B de maneira independente de células T, por um mecanismo mediado por células acessórias, como macrófagos e células dendríticas. Embora não identifiquemos o receptor macrofágico ou das células dendríticas a qual rIutA se liga, sugerimos que a ação de rIutA sobre essas células induz a produção de IL-1 que age sobre seu receptor em células B, induzindo-as a proliferação. Esses resultados abrem perspectivas de estudo de IutA como molécula estimuladora do tecido linfóide associado a mucosa, assim como evasina de E. coli patogênicas. / Indigenous bacteria may contain some virulence factors, such as siderophores iron chelator molecules and fimbriae, that allow these microorganisms to become pathogens in sites others than their normal habitat. Among the different indigenous bacterial species in the gut, Escherichia coli is one with potential to cause infections, mainly urinary tract infection (UTI). Certain strains of E. coli have a plasmid (pColV), which encode ferric aerobactin outer membrane receptor, IutA, often associated with UTI. Our group has recently described IutA as an inducer of B cell proliferation. Here, we identify the molecules and mechanisms that modulate the proliferation of B lymphocytes induced by recombinant IutA (rIutA) from E. coli. To determine whether the B cell proliferation induced by rIutA is dependent on other cell, we carried out assays with CFSE-labeled B cells cocultured separately with macrophages or dendritic cells stimulated with rIutA using transwell membranes or incubated with conditioned medium from these cells. The analysis of the results showed that rIutA indirectly induced the proliferation of B cells in a manner dependent on molecules released by accessory cells. When we analyzed the ability of rIutA in inducing proliferation of cells from mice deficient in adapter molecule MyD88, we found that this signaling molecule is crucial for signaling induced by rIutA in B cells, but not in accessory cells. A similar analysis with cells from mice deficient in Toll like receptor (TLR) 4, TLR2 or inteukin (IL-) 33 receptor revealed that these receptors were not required for rIutA signaling of any tested cells. Conversely, the pretreatment of the B cells with IL-1 receptor antagonist significantly decreased the proliferation of these cells in response to conditioned medium from cultures of IutAstimulated macrophages. Moreover, we determined that rIutA induced the expression of IL-1 in macrophages and dendritic cells stimulated with IutA. Altogether, our results suggest that IutA from E. coli induces polyclonal B-cell proliferation independently of T cells in a mechanism mediated by accessory cells such as macrophages and dendritic cells. Although the IutA-binding receptors from macrophages and dendritic cells have not been identified, we suggested that rIutA induces these cells to produce IL-1, which in turns acts on its receptor on B cells, triggering proliferation. These results open perspectives for studying IutA as a molecule that stimulates the mucosa-associated lymphoid tissue and as an immune-evasion molecule from pathogenic E. coli.
|
6 |
Receptor de aerobactina férrica de Escherichia coli - IutA: um novo antígeno T-independente do tipo 1 / Ferric aerobactin receptor from Escherichia coli IutA: a new type 1 T-independent antigenTaise Natali Landgraf 15 June 2012 (has links)
Alguns fatores de virulência em bactérias de microbiota normal, tais como sideróforos moléculas captadoras de ferro e determinadas fímbrias, possibilitam que esses microorganismos causem infecção quando a colonização ocorre fora de seu habitat normal. Dentre as diferentes espécies bacterianas da microbiota normal com potencial para causar doenças, como as infecções do trato urinário (ITUs), destaca-se Escherichia coli. Certas cepas dessa espécie bacteriana apresentam um plasmídeo (pColV) que contém um gene que codifica IutA, o receptor para a aerobactina férrica, que é um sideróforo frequentemente associado às ITUs. Recentemente, nosso grupo estabeleceu que IutA apresenta a capacidade de induzir proliferação de linfócitos B. Neste trabalho, objetivamos identificar as moléculas e os mecanismos que modulam a proliferação de linfócitos B induzida por IutA recombinante (rIutA) de E. coli. Para avaliar se a proliferação era dependente de outras células, foram realizados ensaios de proliferação de células B marcadas com CFSE utilizando o sobrenadante de macrófagos ou células dendríticas estimulados com rIutA, por 24 horas, ou coculturas em placas de transwell. As análises desses ensaios revelaram que a proliferação das células B induzida por rIutA é dependente de moléculas liberadas por células acessórias, ou seja, ocorre de forma indireta. Os resultados dos ensaios utilizando células deficientes da molécula adaptadora MyD88 mostraram dependência da sinalização por essa molécula nos linfócitos B, mas não nas células acessórias, para que ocorresse a proliferação. Posteriormente, os ensaios in vitro utilizando células de animais deficientes para TLR4, TLR2 e IL-33R mostraram que a sinalização por esses receptores é dispensável. Contrariamente, a utilização do antagonista do receptor de IL-1 reduziu significativamente a proliferação de células B tratadas com esse antagonista. Além disso, identificamos que rIutA leva à expressão de IL-1 em macrófagos e células dendríticas estimuladas com essa proteína. Assim, nossos resultados sugerem que rIutA de E. coli induz a proliferação policlonal de linfócitos B de maneira independente de células T, por um mecanismo mediado por células acessórias, como macrófagos e células dendríticas. Embora não identifiquemos o receptor macrofágico ou das células dendríticas a qual rIutA se liga, sugerimos que a ação de rIutA sobre essas células induz a produção de IL-1 que age sobre seu receptor em células B, induzindo-as a proliferação. Esses resultados abrem perspectivas de estudo de IutA como molécula estimuladora do tecido linfóide associado a mucosa, assim como evasina de E. coli patogênicas. / Indigenous bacteria may contain some virulence factors, such as siderophores iron chelator molecules and fimbriae, that allow these microorganisms to become pathogens in sites others than their normal habitat. Among the different indigenous bacterial species in the gut, Escherichia coli is one with potential to cause infections, mainly urinary tract infection (UTI). Certain strains of E. coli have a plasmid (pColV), which encode ferric aerobactin outer membrane receptor, IutA, often associated with UTI. Our group has recently described IutA as an inducer of B cell proliferation. Here, we identify the molecules and mechanisms that modulate the proliferation of B lymphocytes induced by recombinant IutA (rIutA) from E. coli. To determine whether the B cell proliferation induced by rIutA is dependent on other cell, we carried out assays with CFSE-labeled B cells cocultured separately with macrophages or dendritic cells stimulated with rIutA using transwell membranes or incubated with conditioned medium from these cells. The analysis of the results showed that rIutA indirectly induced the proliferation of B cells in a manner dependent on molecules released by accessory cells. When we analyzed the ability of rIutA in inducing proliferation of cells from mice deficient in adapter molecule MyD88, we found that this signaling molecule is crucial for signaling induced by rIutA in B cells, but not in accessory cells. A similar analysis with cells from mice deficient in Toll like receptor (TLR) 4, TLR2 or inteukin (IL-) 33 receptor revealed that these receptors were not required for rIutA signaling of any tested cells. Conversely, the pretreatment of the B cells with IL-1 receptor antagonist significantly decreased the proliferation of these cells in response to conditioned medium from cultures of IutAstimulated macrophages. Moreover, we determined that rIutA induced the expression of IL-1 in macrophages and dendritic cells stimulated with IutA. Altogether, our results suggest that IutA from E. coli induces polyclonal B-cell proliferation independently of T cells in a mechanism mediated by accessory cells such as macrophages and dendritic cells. Although the IutA-binding receptors from macrophages and dendritic cells have not been identified, we suggested that rIutA induces these cells to produce IL-1, which in turns acts on its receptor on B cells, triggering proliferation. These results open perspectives for studying IutA as a molecule that stimulates the mucosa-associated lymphoid tissue and as an immune-evasion molecule from pathogenic E. coli.
|
7 |
Fyziologická úloha proteinu SIGIRR v časném embryonálním vývoji. / Physiological role of SIGIRR in early embryonic development.Hanusová, Zdeňka January 2012 (has links)
IL-1 receptor/Toll-like receptor (IL-1R/TLR) supefamily represents a group of proteins that share highly conserved TIR domain in their cytoplasmic region. Signal transduction mediated by TIR-containing proteins involves the activation of NF-κB transcription factor and thus the members of this superfamily play a key role in many physiological responses related to innate immune defense and inflammation. SIGIRR (single immunoglobulin IL1R-related molecule) is a recently discovered member of the IL-1R family, however it differs from the other group members by its unique structural features. SIGIRRhas been so far considered to be an 'orphan' receptor as no SIGIRR ligand has been identified yet. Moreover, SIGIRR itself is not capable to induce the NF-κB activation. Instead, SIGIRR is supposed to act as a negative regulator for IL- 1Rs/TLRs mediated inflammation. Its inhibitory function has been implemented in several signalling pathways in various cell types and tissues including the kidney, the digestive tract and the lung. Recent reports also suggest that SIGIRR could play a role in early embryonic development. The main aim of this thesis is to characterize the mechanism how SIGIRR negative regulatory function in IL-1R/TLR signalling pathway is delivered. Here we describe the establishment of...
|
Page generated in 0.043 seconds